Label: LACTULOSE solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 1, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    CI08730222 R02/22 Rx ONLY
  • DESCRIPTION
    Lactulose is a synthetic disaccharide in solution form for oral administration. Each 15 mL of Lactulose Solution contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose ...
  • CLINICAL PHARMACOLOGY
    Lactulose is poorly absorbed from the gastrointestinal tract, and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of ...
  • INDICATIONS AND USAGE
    For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which ...
  • CONTRAINDICATIONS
    Since lactulose solution contains galactose (less than 1.6 g/15 mL), it is contraindicated in patients who require a low galactose diet.
  • WARNINGS
    A theoretical hazard may exist for patients being treated with lactulose solution who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H ...
  • PRECAUTIONS
    General - Since lactulose solution contains galactose (less than1.6 g/15 mL) and lactose (less than 1.2 g/15 mL), it should be used with caution in diabetics. Information for Patients - In the ...
  • ADVERSE REACTIONS
    Precise frequency data are not available. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential ...
  • OVERDOSAGE
    Signs and Symptoms - There have been no reports of accidental overdosage. In the event of overdosage, it is expected that diarrhea and abdominal cramps would be the major symptoms. Medication ...
  • DOSAGE AND ADMINISTRATION
    The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to ...
  • HOW SUPPLIED
    Lactulose Solution, USP 10 g/15 mL is supplied as: NDC 82804-107-47: 16 fl oz (473 mL) bottles - Store at controlled room temperature, 20°to 25°C (68° to 77°F). [See USP] Do not freeze. Under ...
  • MANUFACTURED BY
    Pharmaceutical Associates, Inc. Greenville, SC 29605 - Relabeled By: Proficient Rx LP Thousand Oaks, CA 91320 R02/2022
  • Teratogenic Effects
    Reproduction studies have been performed in mice, rats, and rabbits at doses up to 3 or 6 times the usual human oral dose and have revealed no evidence of impaired fertility or harm to the fetus ...
  • PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label
    NDC 82804-107-47 - Lactulose Solution USP - 10 g/15 mL - Each 15 mL contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose, and 1.2 g or less ...
  • INGREDIENTS AND APPEARANCE
    Product Information